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Membrane orderLaurdan and di-4-ANEPPDHQ are used as probes for membrane order, with a blue shift in emission for
membranes in liquid-ordered (lo) phase relative to membranes in liquid-disordered (ld) phase. Their use as
membrane order probes requires that their spectral shifts are unaffected by membrane proteins, which we
have examined by using membrane inserting peptides and large unilamellar vesicles (LUVs). The
transmembrane polypeptides, mastoparan and bovine prion protein-derived peptide (bPrPp), were added
to LUVs of either lo or ld phase, up to 1:10 peptide/total lipid ratio. The excitation and emission spectra of
laurdan and di-4-ANEPPDHQ in both lipid phases were unaltered by peptide addition. The integrity and size
distribution of the LUVs upon addition of the polypeptides were determined by dynamic light scattering. The
insertion efﬁciency of the polypeptides into LUVs was determined by measuring their secondary structure by
circular dichroism. Mastoparan had an α-helical and bPrPp a β-strand conformation compatible with
insertion into the lipid bilayer. Our results suggest that the presence of proteins in biological membranes does
not inﬂuence the spectra of laurdan and di-4-ANEPPDHQ, supporting that the dyes are appropriate probes for
assessing lipid order in cells.peptide; DLS, dynamic light
oline; DPPG, 1,2-dihexadeca-
lized polarization; GUVs, giant
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There is a need to study cells and their components by biophysical
methods. For biological membranes, the recognition of this need was
intensiﬁed by the lipid raft hypothesis, which suggests that membrane
domainswithdifferent packingefﬁciency exist in theplasmamembrane
[1]. However, several reports ofmembrane domainswith different lipid
compositions in the plasma membrane as well as internal membranes
predate the lipid raft hypothesis [2–5]. Probes like laurdan and di-4-
ANEPPDHQ,whose spectral properties alter in response to lipid packing,
are frequently used to study membrane domains of different lipid
phases in biological membranes. Their utility requires a response solely
to lipid phases. The concentration of proteins is very likely to differ
between different membrane regions [6], and the responses of laurdan
and di-4-ANEPPDHQhave until nownot been extensively characterized
in the presence of membrane proteins.
In model membranes, two liquid phases have been described – the
liquid-ordered (lo) phase and liquid-disordered (ld) phase. Choles-terol is an absolute requirement for the formation of the lo phase, in
which the acyl chains of the phospholipids are extended and the
ﬂuidity is lower [7], but the difference in the cholesterol fraction
between co-existing lo and ld phases is rather small [8,9]. In cells,
whose plasma membranes are comprised of thousands of different
lipids whose phase behavior is largely uncharacterized, it is better to
refer to ordered and disordered domains rather than to use the ld and
lo terminology.
Laurdan and di-4-ANEPPDHQ display blue shifts of around 50 nm
in their emission peaks for model membranes in lo phase relative to
membranes in ld phase [10,11]. The probes operate by the same
mechanisms, i.e. sensing the reorientation of solvent dipoles, which is
related to the level of water penetration into the lipid bilayer [11,12].
However, they report at different depths in the membrane. The
chromophore of laurdan probes the interphase region between the
lipid head groups and the ﬁrst C-atoms of the hydrophobic acyl chains,
whereas the chromophore of di-4-ANEPPDHQ aligns with the acyl
groups deeper in the hydrophobic core. Moreover, laurdan due to its
lack of charge should, like cholesterol, easily ﬂip between the two
leaﬂets on a timescale of seconds [13] while di-4-ANEPPDHQ with its
two positive charges should have a considerably lower ﬂipping ability
comparable to that of the local anaesthetic tetracaine that does not ﬂip
at all on an hour timescale [14].
The relative proportion of lo/gel phases and ld phase in a sample
can be assessed by generalized polarization (GP) [15]. Importantly, for
a membrane with two co-existing phases, a variation in the GP-value
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in the relative proportion of the two phases. However, the
composition of different ld and lo phases varies and so do their
characteristics. That a diverse range of ordered and disordered
domains can be formed by plasma membrane lipids was recently
demonstrated by measuring the laurdan GP-values of plasma
membrane vesicles formed using different methods [16].
The organization of the plasma membrane should be considered
from the perspective of both lateral domain formation and cell
topography [17,18]. In addition to reporting on the order of the
bilayer, laurdan can also report on membrane orientation, when
illuminated by polarized light – a characteristic termed photoselec-
tivity [19]. It seems likely that also di-4-ANEPPDHQ can be used to
study membrane orientation, although this has not been veriﬁed.
Confusingly, photoselectivity can also be also used to describe laurdan
excitation preferences in membranes of different phases. Laurdan in
gel phase is preferentially excited at the red end of the excitation
range and laurdan in ld phase is preferentially excited at the blue end
of the excitation range [20].
Although laurdan in model membranes undoubtedly reports on the
lipid order [21,22], questions have been raised about its behavior in the
presence of membrane proteins. In this study, we used two structurally
well-characterized polypeptides, the wasp venom protein mastoparan
[23] and the 30N-terminal residues of bovine prion protein [24,25] that
insert in large unilamellar vesicles (LUVs) either withα-helix structure
or with β-structure. These peptides represent different aspects of
membrane-inserted polypeptides and were here used to assess the
effects on laurdan and 4-ANEPPDHQ spectral properties.2. Materials and methods
2.1. Materials
The phospholipids were from Avanti Polar Lipids (Alabaster,
Alabama), and cholesterol was from Nu-Chek Prep, Inc. (Elysian, MN).
6-Dodecanoyl-2-dimethyl-aminonaphthalene (laurdan) was from Mo-
lecular Probes (Invitrogen, Carlsbad, CA), anddi-4-ANEPPDHQwas from
Lesley Loew (University of Connecticut Health Center, CT). Mastoparan
and custom made bovine prion protein-derived peptide consisting of
the 30 N-terminal amino acid residues were obtained from Neosystem
Laboratories (Strasbourg, France).2.2. Large unilamellar vesicle preparation
LUVswere prepared as described previously [26–28]. Brieﬂy, lipids
were dissolved in a mixture of chloroform: methanol (13:5 v/v). To
produce a ﬁlm of lipids, the solution was dried to under a stream of
nitrogen for 30 min. The lipid solutions were then lyophilized for
30 min. The dry lipids were dissolved in phosphate-buffered saline
(PBS), to produce a suspension of large multilamellar vesicles.
Samples were vortexed and incubated at room temperature for 1 h.
In order to decrease the lamellarity, the solutionwas then subjected to
ﬁve fast freeze–thaw cycles, moving the sample between liquid
nitrogen and a 40 °C waterbath. To obtain LUVs, the lipid solutions
were extruded 21 times through a polycarbonate ﬁlter with a pore
size of 100 nm (Whatman Plc., UK) in an Avanti manual extruder. The
lo phase was made up of sphingomyelin, 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) spiked with 5% 1,2-dihexadecanoyl-sn-
glycero-3-phospho-(1′-rac-glycerol) (DPPG) and cholesterol at
1:1:2, and the ld phase by DOPC spiked with 5% DPPG. Laurdan,
from an ethanol stock, was added to lipid mixture in 1:1000 dye-to-
lipid ratio before drying the samples. Di-4-ANEPPDHQ from water
stock was added to the lipid mixture at a 1:1000 dye-to-lipid ratio
after dissolving the lipids in buffer.2.3. Giant unilamellar vesicle preparation
Giant unilammelar vesicles (GUVs) were prepared basically
according to Akashi et al. [29] from the same lipid mixes as the
LUVs. Brieﬂy, lipids from their respective stocks were added to
chloroform:methanol (2:1). Samples were subjected to rotary
evaporation for 10 min at 50 °C to obtain a dry ﬁlm of lipids.
Subsequently, samples were exposed to high vacuum for 2 h and
then left at a water bath at 50 °C under a stream of nitrogen for
30 min. The dry lipid ﬁlms were dissolved in 5 mM PIPES, 50 mM KCL,
and 1 mM EDTA at pH 7.0 and placed on a heating block at 50 °C for
24 h. Samples were then slowly cooled over period of 4 h in a
styrofoam box.
2.4. Fluorescence spectroscopy
All ﬂuorescence spectroscopy measurements were carried out
using a Fluorolog 3 spectroﬂuorometer (HORIBA Jobin Yvon Inc.,
Edison, NJ) at 25 °C. The laurdan and the di-4-ANEPPDHQ emission
and excitation spectra were measured for both lo and ld phases 1 mM
LUVs before and after the addition of polypeptides. The laurdan
emission spectrumwasmeasured from 370 to 620 nmwith excitation
at 350 nm. The di-4-ANEPPDHQ emission spectrum was measured
from 500 to 700 nm with excitation at 488 nm. Laurdan excitation
spectra were measured between 300 and 405 nm (with the emission
measured at 430 and 450 nm for lo and ld phases, respectively), and
di-4-ANEPPDHQ excitation spectra were measured between 400 and
520 nm (with the emission measured at 580 and 600 nm for lo and ld
phases, respectively). The ﬂuctuations in lamp intensity over the
selected wavelength were corrected for in the excitation spectra. The
emission and excitation spectra were acquired with a 1- or 2-nm
bandwidth and a background subtraction for PBS was performed for
all emission and excitation spectra. Where indicated, the spectra were
subjected to either rolling average, automated Fourier transform
smoothing, or corrected for the wavelength dependence of the
monochromators, but most spectra are from raw data. Two mem-
brane interacting peptides, mastoparan (a 14-residue peptide toxin
isolated from wasp venom) and the 30 N-terminal residues from
bovine prion protein (bPrPp), were added from freshly made stock
solutions to LUVs stained with laurdan or di-4-ANEPPDHQ at 1:1000,
1:100, and 1:10 protein-to-total lipid ratio.
2.5. CD spectroscopy
Circular dichroism (CD)measurements for the two peptides in two
phospholipid vesicle solvents were made on a Chirascan CD spectro-
polarimeter (Applied photophysics, Leatherhead, UK) with a 50-μm
quartz cuvette. Spectra were recorded for solutions containing 2.5–
5 mM phospholipids and 250–500 μM peptide (lipid:protein ratio
10:1) in PBS. Wavelengths between 190 and 250 nm were measured,
with a 1-nm step resolution and 100 nm/min scan speed. The
response time was 4 s, with 50 mdeg sensitivity and a 0.5- or 1-nm
bandwidth. Measurements were conducted at 25 °C, and the
temperature was controlled by a TC 125 temperature controller
(Quantum Northwest Inc., Seattle, WA). Spectra were collected and
averaged over ten scans. The CD spectra were evaluated using Applied
Photophysics Pro-Data viewer v 4.0.17. The amount of secondary
structure elements was evaluated using the DICHROWEB software
[30–32].
2.6. Dynamic light scattering
The integrity and size distribution of the LUVs upon addition of the
polypeptides were determined by dynamic light scattering (DLS)
experiments at 25 °C on 2.5 mM LUVs dissolved in PBS. DLS
measurements were recorded on an ALV/CGS3 goniometer system
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collected over 60 s with three scans per sample and presented as an
averaged correlation function. The data were processed with the
manufacturer's software to obtain the unweighted radius.
3. Results
Laurdan has been used for decades to characterize phase co-
existence in both model membranes and cells, due to its different
spectra in ld relative to lo/gel phase [21,33,34]. Di-4-ANEPPDHQ was
introduced more recently as an attractive alternative to laurdan,
primarily for live cells, mainly due to its solubility in water rather than
in organic solvent and its excitability within the visible rather than the
UV range [10,12]. Both dyes would be excellent tools for examining
order in biological membranes if it can be demonstrated that the
change in their emission reﬂects only membrane order. The crucial
characterization of the response of laurdan and di-4-ANEPPDHQ to
membrane-inserted peptides has now been performed.
3.1. The spectral properties of laurdan and di-4-ANEPPDHQ are not
affected by membrane inserting peptides
LUVs of lo phase were prepared from sphingomyelin, DOPC, and
cholesterol at 1:1:2 and ld phase LUVs from DOPC [8]. The DOPC
contained 5% of the negatively charged lipid DPPG to enable formation
of giant unilamellar vesicles (GUVs) by the gentle hydration method
for comparative studies [29]. For the purpose of this study, phosphate
determination was considered unnecessary. Laurdan was mixed with
the lipids prior to LUV formation, whereas di-4-ANEPPDHQ, which is
water-soluble, was added directly to LUVs, both at a 1:1000 ratio in
relation to the lipids. The laurdan emission spectra in DOPC LUVs had
a peak around 483 nm and in lo phase LUVs, around 433 nm (Fig. 1A
and B). In ld phase LUVs, there was also a second emission peak at
around 452 nm. The variation in intensities of the peaks at 452 and
483 nm between experiments is possibly the result of different
batches of DOPC.
The small shoulder around 400 nm in the ld spectra is likely to be
the result of insufﬁcient correction for PBS peak at this wavelength,
caused by the high sensitivity of cuvette positioning in the
spectrophotometer. The emission spectra of laurdan in GUVs were
identical to those of laurdan in LUVs of the same lipid compositions
(not shown). Mastoparan or bPrPp was sequentially added to the
LUVs to achieve a 1:1000, 1:100, and 1:10 peptide-to-lipid ratio. This
did not cause any alteration in either in the appearance of the spectra
or in the positions of the excitation and emission peaks. The excitation
spectra for laurdan peaked at 358 nm in both ld and lo phase LUVs
(Fig. 2A and B). The addition of either mastoparan or bPrPp did not
affect the laurdan excitation spectra in either ld or lo phase.
The di-4-ANEPPDHQ emission spectra in lo LUVs had a peak
maximum around 585 nm and in ld phase LUVs around 597 nm
(Fig. 1C and D). The addition of mastoparan or bPrPp to achieve aFig. 1. The effect of membrane-inserted peptides on the emission spectra of laurdan and
di-4-ANEPPDHQ. lo phase LUVs were prepared mixing sphingomyelin, DOPC spiked
with 5% DPPG and cholesterol in 1:1:2 ratio. ld phase LUVs were made of DOPC spiked
with 5% DPPG. Two different transmembrane polypeptides, mastoparan or bPrPp, were
added to lo and ld phase LUVs stained with laurdan or di-4-ANEPPDHQ in 1:1000, 1:100
or 1:10 peptide/total lipid ratio, and their emission spectra were measured at 350 and
488 nm excitation wavelength, respectively. Fluorescence intensity values were
normalized to the sample with no added peptide. (A) lo and ld emission spectra of
laurdan after addition of mastoparan. (B) lo and ld emission spectra of laurdan after
addition of bPrPp. (C) lo and ld emission spectra of di-4-ANEPPDHQ after addition of
mastoparan. (D) lo and ld emission spectra of di-4-ANEPPDHQ after addition of bPrPp.
The spectra in panel B were smoothened using a rolling average and the spectra in panel
D were smoothened using Fourier transformation. Spectra shown are representative of
ﬁve experiments.1:1000, 1:100, or 1:10 peptide-to-lipid ratio did not affect the position
of the emission peaks nor the appearance of the spectra. The
excitation spectra for di-4-ANEPPDHQ in both ld and lo phase LUVs
peaked at 470 nm (Fig. 2C and D). The addition of either mastoparan
or bPrPp did not affect the di-4-ANEPPDHQ excitation spectra in
either ld or lo phase. The reason for there only being a modest
difference between the emission peaks in LUVs of different phases is
Fig. 2. The effect of membrane-inserted peptides on the excitation spectra of laurdan
and di-4-ANEPPDHQ. lo phase LUVs were prepared mixing sphingomyelin, DOPC
spiked with 5% DPPG and cholesterol in 1:1:2 ratio. ld phase LUVs were made of DOPC
spiked with 5% DPPG. Two different transmembrane polypeptides, mastoparan or
bPrPp, were added to lo or ld phase LUVs stained with laurdan or di-4-ANEPPDHQ in
1:1000, 1:100, and 1:10 peptide/total lipid ratio, and their excitation spectra were
measured from 320 to 405 nm for laurdan and from 400 to 520 nm for di-4-ANEPPDHQ.
Fluorescence intensity values were normalized to the sample with no added peptide.
(A) lo phase, laurdan, and mastoparan or bPrPp. (B) ld phase, laurdan, and mastoparan
or bPrPp. (C) lo phase, di-4-ANEPPDHQ, and mastoparan or bPrPp. (D) ld phase, di-4-
ANEPPDHQ, and mastoparan or bPrPp. Spectra shown are representative of three
experiments.
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studying peptide insertion into the membrane (Supplementary
Fig. 1).
Our results suggest that the presence of peptides or proteins in
biological membranes does not inﬂuence the spectra of laurdan and
di-4-ANEPPDHQ and that the dyes thus report exclusively on lipid
order.
3.2. Mastoparan and bPrPp insertion does not affect the integrity of
the LUVs
The insertion of peptides into LUVs could alter their size and/or
stability. The peptides may be fusogenic, cause vesicle ﬁssion, or
simply increase the LUV size. To examine whether LUVs were affected
by mastoparan or bPrPp, their integrity and size distribution were
determined by dynamic light scattering. The mean diameter of the ld
phase DOPC vesicles varied between 67 and 120 nm, while the
diameter for lo phase sphingomyelin:DOPC:cholesterol (1:1:2)
vesicles varied between 74 and 204 nm. With the exception of one
experiment, the LUVs in lo phase were considerably larger than the
LUVs in ld phase. The ld phase LUVs displayed a much more
homogenous size distribution than the lo phase LUVs. Insertion of
mastoparan did not affect the position of the peak for the
hydrodynamic radius of the LUVs at the 1:100 and the 1:1000
peptide-to-lipid ratios in either ld or lo phase, but at the highest
concentration, there was a asymmetric shift in both phases, indicating
that there were on average larger vesicles as well as a wider spread of
vesicle sizes (Fig. 3A–D). Intensity correlation functions are shown for
all mastoparan experimental conditions in Supplementary Fig. 2A–D.
Insertion of bPrPp at the ratios 1:1000 or 1:100 did not affect the
position of the peak for the hydrodynamic radius of either ld or lo
phase LUVs, but at the 1:10 ratio, a slight shift of the peak to a higher
value occurred in most experiments (Fig. 3E–H). The peak shift was
accompanied by an asymmetric shift of the mean size of the radius,
consistent with a wider distribution of vesicle sizes and somewhat
larger vesicles after peptide addition. Intensity correlation functions
are shown for all bPrPp experimental conditions in Supplementary
Fig. 2E–H.
It is clear from all curves that the addition of the peptides caused
either disintegration nor fusion of the LUVs. The increase in vesicles
size is compatible with peptide insertion into the membrane.
3.3. Mastoparan and bPrPp are inserted into the LUVs with different
secondary structures
The increase in vesicular size in the presence of peptides clearly
suggested that mastoparan and bPrPp inserted into the vesicles, but to
conﬁrm the membrane insertion further, we examined the structural
conversion of the peptides in the presence of LUVs. In water solution,
both peptides have a random coil conformation. Mere membrane
association may not induce changes in their conformation, whereas
distinct structural features should be observable upon membrane
insertion.
To ensure that the two peptides were inserted into the vesicles in
the presence of the two dyes, the structure induction in the two
peptides was measured by far-UV CD spectra. First, note that for both
peptides and both dyes, the results were very similar (Fig. 4).
Mastoparan clearly becomes mainly α-helical when inserted into
vesicles of either ld or lo phase mixture. It also appears that the
peptide is more structured in the vesicles with the lipids in the ld
phase (Fig. 4A and C). On the other hand, the bPrPp CD spectrum has a
different appearance, with a large proportion of β-strand structure
(Fig. 4B and D). This is in line with a previous study demonstrating
that bPrPp has β-strand structure in the presence of negatively
charged lipids [25], which was an additional reason for the inclusion
of the negatively charged DPPG in the LUVs.
Fig. 3. Hydrodynamic radius of LUVs increases after addition of membrane inserting peptide. The integrity and size distribution of the LUVs upon addition of the transmembrane
polypeptides were determined by dynamic light scattering. The measurements for both laurdan- and di-4-ANEPPDHQ-stained vesicles were repeated with the addition of
mastoparan bPrPp in 1:1000, 1:100, and 1:10 peptide/total lipid ratio. Figure shows hydrodynamic radius distribution of lo and ld LUVs before and after addition of transmembrane
peptide. Addition of transmembrane peptides increases the mean radius and size range of LUVs. (A) Laurdan, ld phase and mastoparan. (B) Di-4-ANEPPDHQ, ld phase and
mastoparan. (C) Laurdan, lo phase and mastoparan. (D). Di-4-ANEPPDHQ, lo phase and mastoparan. (E) Laurdan, ld phase and bPrPp. (F) Di-4-ANEPPDHQ, ld phase and bPrPp. (G)
Laurdan, lo phase and bPrPp. (H). Di-4-ANEPPDHQ, lo phase and bPrPp. The experiments were repeated between two and four times.
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For mastoparan, we found that the peptide structure is around 80%
helical in the ld phase and around 60–70% helical in the lo phase, with
the rest being in a random coil conformation. This is in agreement with
what is known of mastoparan's interactions with model membranes
[23,35]. The results for the bovineprion protein-derivedpeptide, in bothld and lo lipid mixtures, indicate the presence of around 15–20% helix
and around50–60%β-sheet structure,with the rest being randomcoil. It
has previously been observed that the prion-derived peptide interacts
with phospholipid vesicles to obtain either α-helical or β-sheet
structure, depending on the lipid composition [25]. The CD analysis
clearly demonstrates that the peptides insert into the bilayers of the
Fig. 4. Insertion efﬁciency of transmembrane polypeptides into LUVs. The insertion
efﬁciency of the polypeptides into LUVs was determined by measuring their 3D
polypeptide structure by circular dichroism. Spectra were recorded for solutions
containing 2.5–5 mM phospholipids and 250–500 μMpeptide (lipid:protein ratio 10:1)
in PBS buffer. Wavelengths between 190 and 250 nmwere measured, with a 1-nm step
resolution and 100 nm/min. Measurements were conducted at 25 °C. (A) Mastoparan
spectra in lo and ld phase LUVs stained with laurdan. (B) Mastoparan spectra in lo and
ld phase LUVs stained with di-4-ANEPPDHQ. (C) bPrPp spectra in lo and ld phase LUVs
stained with laurdan. (D) bPrPp spectra in lo and ld phase LUVs stained with di-4-
ANEPPDHQ. Spectra shown are representative of three experiments.
Fig. 5. The effect of negative charge and hydrophobic mismatch on the emission spectra
of laurdan and di-4-ANEPPDHQ. Liposomes were prepared from DOPC, DOPC plus 5%
DPPC, or DOPC plus 5% DPPG and stained with laurdan or di-4-ANEPPDHQ. The
emission spectra were measured at 350- and 488-nm excitation wavelength,
respectively. Fluorescence intensity values were normalized to the DOPC samples.
Spectra shown are representative of two experiments. (A) Emission spectra of laurdan.
(B) Emission spectra of di-4-ANEPPDHQ.
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the added dyes.4. Discussion
There is a heated debate about whether lipid domains exist in
biological membranes. It mainly reﬂects a lack of methods for
resolving membrane regions that may be smaller than 20 nm in
diameter [36,37]. Laurdan and di-4-ANEPPDHQ are well suited to
address lipid domain questions, since they report on the relative
proportions of ordered and disordered domains, regardless of the size
of the individual domains. Their use is therefore increasingly popular,
but objections are frequently raised that the dyes may not report
exclusively on lipid packing but that the spectra may be inﬂuenced by
interactions with proteins. To address to this caveat, we have
performed a careful study on the effect of membrane-inserted
peptides of both α-helical and β-strand structure on the spectra of
the two dyes in different membrane phases. We found no changes in
their spectra.
Membrane curvature and lateral membrane tension are other
features that may affect the spectral properties of probes assigned to
report on membrane order. The higher the curvature, the lower the
lateral membrane tension, which means that more water molecules
can penetrate into the bilayer and increase its ﬂuidity. This implies
that lower laurdan excitation GP values indicate a higher curvature
[38]. However, GP reports on the mobility of the water molecules
rather than their number and low GP values do not necessarily mean
that more water molecules enter the bilayer. In a study of Prodan, a
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ﬂuidity and solvent relaxation rates increase with membrane
curvature, the Stokes shift was not affected [39]. This is compatible
with an increase in the mobility of the water molecules, an increase in
the number of water molecules in the bilayer, or an increase in both.
It has been reported that high concentrations of laurdan in cells
enable FRET between the donor tryptophan (Trp) residues in
membrane proteins and the acceptor laurdan [40]. bPrPp contains
two Trp residues at positions 9 and 18 that are in its membrane-
inserted region [25]. FRET between these Trps and laurdan would
effectively cause a new peak to appear in the laurdan excitation
spectra below 310 nm, but no difference in the laurdan excitation
spectra in the UV region was observed upon bPrPp addition (not
shown). The absence of spectral changes when bPrPp was used (at a
peptide-to-lipid ratio of 1 to 10) in the presence of laurdan (at a dye-
to-lipid ratio of 1 to 1000) suggests both that laurdan is not found in
the vicinity of Trps and the ﬂuorescence of Trp itself is weak
in comparison to that of laurdan. This is a likely result of bPrPp
having β-structure rather than α-helical structure since the Trps are
then not expected to be as close to the membrane interphase where
the ﬂuorophore moiety, the naphthalene ring, of laurdan resides
[41,42]. It is also possible that the membrane-inserted peptides
aggregate and that laurdan prefers a pure lipid environment and
therefore avoids the aggregated areas. Moreover, most wavelengths
and ﬁlters used for laurdan excitation would not excite Trp, making
any Trp–laurdan FRET irrelevant. For instance, in a study where the
laurdan excitation GP values were reported to decrease as the
laurdan-to-cell ratio increased, the excitation wavelength employed
precludes FRET between Trp and laurdan [43]. Since laurdan
partitions equally to ordered and disordered domains [44], self-
quenching also seems an unlikely cause of the reported decrease in GP
values [43], but the distribution of phases may cause preferential self-
quenching in the ordered phase.
Laurdan in DOPC spiked with 5% DPPG emits more in the blue part
of the spectra than laurdan in pure DOPC [19], with the peaks at 452
and 483 nm being of more equal height. However, this was the result
of hydrophobic mismatch (Appendix A) supporting a study claiming
that the head groups of phospholipids are not responsible for the
spectral properties of laurdan [45]. We have chosen the emission peak
at 483 nm for comparisons in this study since it gives the shift of
50 nm between lo and ld phases anticipated for laurdan. However, the
spectra were not affected by peptide insertion into the LUVs so our
conclusions would have been the same regardless of the peak selected
for analysis.
Several studies have indicated that laurdan's emission spectrum is
not affected by the presence of membrane proteins. When comparing
laurdan emission in electric tissue from Torpedo marmorata with that
in liposomes made from lipids extracted from the same tissue, no
differenceswere detected [46]. Recently, it was shown that a synthetic
peptide did not affect laurdan GP values in LUVs when mixed with
lipids up to a 1-in-50 ratio [16]. However, it was not shown that the
peptide was inserted in the LUVs and a 1-to-50 ratio is likely to be an
underestimate of the in vivo situation [47]. In the present study, a level
of insertion of at least 60% was conﬁrmed, based on the structure
induced in the peptides, and peptide-to-lipid ratios of up to 1 to 10
were used. This degree of peptide prevalence is comparable with the
in vivo situation since estimations predict that the plasma membrane
is crowded with proteins [47].
While laurdan can interact with proteins in water solution [3],
there is, to the best of our knowledge, no evidence suggesting that
laurdan interacts with proteins in membranes. By measuring FRET
between tryptophans in acetylcholine receptors and laurdan, it was
concluded that the dye was randomly distributed in the membranes,
showing no afﬁnity for the protein [46]. Nor did laurdan avoid the
acetylcholine receptors. Interestingly, it was demonstrated that
laurdan molecules in close proximity to the acetylcholine receptorswere in a more ordered environment than laurdanmolecules found in
the bulk membrane [46], suggesting that membrane proteins need
not have global effects on membrane order. This is also the case for
peptides that insert parallel to themembrane surface [48]. The dyes in
our lipid mixes may avoid the areas close to the peptides, and if the
peptides aggregate, there should be plenty of regions devoid of
peptides. This would be reminiscent of the situation where the
laurdan relative Patman only inserts in the lipid part of phospholipid-
poly(diacetylene) vesicles [49]. The lack of FRET between Trps in
bPrPp and laurdan supports this interpretation. On the other hand, the
lack of effect on the emission spectra of both laurdan and di-4-
ANEPPDHQ strongly suggests that the membrane order in the lipid
mixes used, DOPC and SM:DOCP:chol (1:1.:2) with 5 mol% DPPG in
the DOPC, is not affected by mastoparan or bPrPp insertion as is the
case for a range of other membrane inserting peptides [48]. It is also
reassuring that laurdan itself does not alter the membrane order [50].
It has previously been reported that bPrPp has a signiﬁcant effect
on membrane dynamics and order [51] and that it can cause leakage
in both cells andmodel membranes [25]. However, the leakage occurs
at far lower concentrations than those that alter diphenylhexatriene
ﬂuorescence polarization (membrane order at the hydrophobic core
of the bilayer) and the two can therefore not be equated [25].
Prothrombin, which interacts with membranes, has been reported to
have an effect on the solvent relaxation rate of Patman, a probe that
inserts inmembranes similarly to laurdan [52].Whilemastoparan and
bPrPp insert into the hydrophobic core of the bilayer, prothrombin
forms a complex with negatively charged head groups and calcium
ions in the hydrophilic part of the membrane, which may account for
the difference. Nonetheless, the membrane inserting peptides
magainin, melittin, and KAL have also been reported to affect the
solvent relaxation rate of Patman, especially in the presence of
negatively charged lipids [49]. An explanation for the difference
between our results with laurdan and the peptides mastoparan and
bPrPp and those with Patman and other peptides is that a change in
the solvent relaxation rate does not of necessity alter the Stokes shift
[39]. We would also like to emphasize that although our data support
the interpretation that the membrane order is not affected by
mastoparan and bPrPp insertion in the lipid mixes we used, time-
resolved solvent relaxation studies may produce a more nuanced
answer. Nevertheless, our data clearly demonstrate that the spectral
properties of laurdan and di-4-ANEPPDHQ are not affected by the
insertion of membrane peptides.
The secondary structure of bPrPp has previously been found to
depend on factors such as relative peptide concentration, salt
concentration, and lipid head group properties and can vary between
α-helix and β-sheet [25,51]. Here we ﬁnd that the peptide adopts a
combination of mainly β-sheet with some α-helical structure, which
is in agreement with the previous results in bilayers that contain
negatively charged phospholipids [25]. The wasp venom mastoparan,
on the other hand, adopts a clear α-helical structure when interacting
with the lipid bilayers in the LUVs, which is consistent with previous
work [23,53,54]. Mastoparan has the ability to form transient pores
[55] and can switch between a transmembrane and in-plane
orientation, which is believed to contribute to membrane leakage
[56]. The different properties of the two peptides make them
representative of membrane-inserted proteins.
5. Conclusions
Our results demonstrate that, despite variations in secondary
structure and the knownmembrane-perturbing effects of mastoparan
and bPrPp, neither peptide has any signiﬁcant effect on either laurdan
or di-4-ANEPPDHQ. Hence, our ﬁndings suggest that the dyes report
exclusively on changes in the membrane phase properties and are not
inﬂuenced by the presence of peptides or proteins. Laurdan and di-4-
ANEPPDHQ are well suited for assessing lipid order in cells.
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Appendix A
We are intrigued by the blue shift of laurdan in DOPC LUVs
containing 5% DPPG and have examined this phenomenon in great
detail. To distinguish an effect of charge, present in DPPG but not in
DOPC, from that of a hydrophobic mismatch caused by DPPG having
longer acyl chains than DOPC, we compared the spectra of both dyes
in pure DOPC, DOPC+5 mol% DPPG and DOPC+5 mol% DPPC. The
increase in the laurdan emission peak at 452 nm was due to the
presence of longer acyl chains, not the charge (Fig. 5A). The emission
spectra of di-4-ANEPPDHQ were to our surprise not sensitive to the
presence of either 5 mol% DPPG or 5 mol% DPPC. In pure DOPC, di-4-
ANEPPDHQ also had an emission peak at 590 nm (Fig. 5B). Since di-4-
ANEPPDHQ has two positive charges, it is possible that its spectral
properties are sensitive to pH. We therefore compared the emission
spectra of di-4-ANEPPDHQ in DOPC LUVs in PBS and buffers at pH 3.8
or 8.8. The spectra were identical in all three solvents strongly
suggesting that the emission spectra of di-4-ANEPPDHQ are not
sensitive to alternative protonation of the dye.
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